The U.S. Army Medical Research and Materiel Command will give the
Karmanos Cancer Institute $4.6 million to help fund Cancer Research at the Detroit cancer center.
The
$4.6 million in federal funds will go to the Institute’s National
Oncogenomics and Molecular Imaging Center over the next two years. That
money will go toward developing the technology for the diagnosis of
human cancer by defining oncogene signatures that characterize cancers
in individual patients.
Oncogenes are the mutated forms of
genes that cause normal cells to grow out of control and become cancer
cells. Karmanos will create the imaging technology that will improve
detection of these genes that cause cancer. It will also measure the
response of the cancer treatment.
The bottom line is this new
type of cancer biology could allow doctors to tailor more treatments
for specific patients, cutting out unneeded toxicity during treatment.
The reasearch will be shared with military hospitals around the world.
Source: Karmanos Cancer Institute
Writer: Jon Zemke